US House Restricts EPA's Scientific Advisory Board

The US House of Representatives, now with a Republican party majority, is seeking to make good on its pledge to declaw the Environmental Protection Agency, EPA. Earlier this week the House passed a bill that would change the rules for appointing members to the Science Advisory Board (SAB), which provides scientific advice to the agency.

Among many other things, the bill bans the advisory board's members from participating in activities that directly or indirectly involve review or evaluation of their own work. A scientist who has published a peer-reviewed paper on a particular topic, for example, would not be able to advise the EPA on the findings contained within that paper.

The administration of US President Barack Obama said it would veto the bill, which it said would negatively affect the appointment of experts and would weaken the scientific independence and integrity of the SAB.

Andrew A. Rosenberg, director of the Union of Concerned Scientists, wrote a letter to House Representatives saying the bill "effectively turns the idea of conflict of interest on its head, with the bizarre presumption that corporate experts with direct financial interests are not conflicted while academics who work on these issues are."

An evaluation by a scientist with expertise on topics the Science Advisory Board addresses likely will have done peer-reviewed studies on that topic, making the opinion more valuable, not less, Rosenberg added.

 

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.